跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRUKINSA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BRUKINSA
Authorized
STANDARD
BRUKINSA
beigene switzerland gmbh
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bde38f141036e18b
Company
beigene switzerland gmbh
Type
Standard
Approval Details
Approval Id
bde38f141036e18b
Drug Approval Canada Name
BRUKINSA
Product Name
BRUKINSA
Status
Marketed
Status Date
2021-03-30
Original Market Date
2021-03-30
Din
02512963
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EL03 ZANUBRUTINIB
Atc Name
l 01 el 03
Aig Number
0162766001
Company Name
beigene switzerland gmbh
Company Address
Aeschengraben 27, 21st Fl, Basel, --, Switzerland, 4051
Active Ingredients
ZANUBRUTINIB
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bde38f141036e18b
Type
Standard
Back to Health Canada Approvals